About 1,980,768 results (1,117 milliseconds)

EP1874313A1 - Treatment or prevention of ovarian hyperstimulation ...

https://patents.google.com/patent/EP1874313A1/en
... 7 to about 28 days after administration of gonadotropin for ovarian stimulation. In an alternative embodiment, the dopamine agonist is administered for a ...

WO2019036032A1 - Pregnancy clock proteins for predicting due ...

https://patents.google.com/patent/WO2019036032A1/en
... before 270 days from a pregnancy that delivers on or after 280 days. [00265] ... 7 days. A significant model is defined as one that retains features (is ...

US8048869B2 - Pharmaceutical composition for use in hormone ...

https://patents.google.com/patent/US8048869B2/en
Daily vaginal lavages continued to be obtained for 7 days after dosing was ... for seven (7) days would contain approximately 20 mg of the estrogen.

Miscarriage Research - Miscarriage Statistics

https://sites.google.com/site/miscarriageresearch/miscarriage-general
After two miscarriages, one still has a 91.2% chance of successful pregnancy; drops to 20% after 7 ... Conceiving on the day of, or just before ovulation, halves ...

US7723289B2 - PIF tetrapeptides - Google Patents

https://patents.google.com/patent/US7723289B2/en
NK cells did not appear to bind sPIF-1 15 (SEQ ID NO: 13) even after several days in culture with PHA. PIF Likely Acts Through an Inducible Unique Immune Cell ...

WO2019195796A1 - A leptin receptor agonist antibody for use in ...

https://patents.google.com/patent/WO2019195796A1/en
... day 13 post-HDD (7 days after treatment). Fat mass, lean mass bone mass ... Blood glucose levels were reduced 2 days after initiating H4H17319P2 or ...

US11793760B2 - Orodispersible dosage unit containing an estetrol ...

https://patents.google.com/patent/US11793760B2/en
... ovulation (inhibition). All these effects of estetrol were dose-dependent with ... 7 days after birth. The international patent application describes a ...

US9452175B2 - Pregnancy hormone combination for treatment of ...

https://patents.google.com/patent/US9452175B2/en
... days when withdrawal bleeding occurs. It is known to bridge the taking ... Am J Reprod Immunol, 28:226-7 (1992). Nishibe et al., "Effect of estriol and ...

US20130102614A1 - Chirally pure isomers of itraconazole for use ...

https://patents.google.com/patent/US20130102614A1/en
Angiogenesis is an important step in ovulation and also in implantation of the blastula after fertilization. ... days 7 and 10 post-transduction, respectively.

US7435745B2 - Methods and compositions for inhibition of ...

https://patents.google.com/patent/US7435745
Angiogenesis is an important step in ovulation and also in implantation of the blastula after fertilization. Prevention of angiogenesis could be used to induce ...

CA2261748A1 - Biphasic contraceptive method and kit comprising a ...

https://patents.google.com/patent/CA2261748A1/en
... bleeding), and minim~l side effects. Combination oral ... Placebo is ~rlmini~tered for 7 days following the 21-day con~-~c~live steroid regimen.

CA2643973A1 - Pharmaceutical composition containing butea ...

https://patents.google.com/patent/CA2643973A1/en
... 7 days and quantified by alizarin extraction method (Figure 13). In ... Femur bones are isolated from chick embryos on day 11 post-ovulation and ...

WO2018177746A1 - A gnrh antagonist for use in the treatment of a ...

https://patents.google.com/patent/WO2018177746A1/en
Tail-blood samples were collected for LH measurements twice before the beginning of the treatments, and at day 2 and 6 of each treatment as well as 4 days after ...

WO2018024912A1 - Méthode de gestion de la dysménorrhée et de ...

https://patents.google.com/patent/WO2018024912A1/fr
... 7 days whereby withdrawal bleeding, simulating the natural menses, occurs. ... Dysmenorrhea pain was defined as pelvic pain during the menstrual/withdrawal ...

DE69829501T2 - TREATMENT OF POST-CLIMATIC WOMEN ...

https://patents.google.com/patent/DE69829501T2/en
As an example, one would transdermal patch according to the present invention Invention designed to deliver 10 μg of estrogen per day for seven (7) Days to ...

US8329750B2 - Methods for treating vasomotor symptoms using ...

https://patents.google.com/patent/US8329750B2/en
After day 7, the subject is administered 1800 mg/day gastric retentive ... Blood samples were taken over a 24-hour period after the first dose during ...

WO2004002503A1 - Compositions and methods for treating ...

https://patents.google.com/patent/WO2004002503A1/en
She did report that she had only had mild Endometriosis symptoms on 3 occasions in the time since the second consultation. Example 7: Case Study 3. Patient 3 ...

US20070254025A1 - Oral contraceptive and acne medication ...

https://patents.google.com/patent/US20070254025A1/en
Thus, in a preferred regimen, phase one would commence sometime between day 1 and day 7 of the menstrual cycle and last about 21 days. [0030]. The ...

WO2008124132A1 - Chirally pure isomers of itraconazole and ...

https://patents.google.com/patent/WO2008124132A1/en
Angiogenesis is an important step in ovulation and also in implantation of the blastula after fertilization. ... days 7 and 10 post-transduction, respectively.

US20040147558A1 - Synthesis of 3-amino-thalidomide and its ...

https://patents.google.com/patent/US20040147558A1/en
Rapid tumor expansion occurs within 24 hours after the onset of neovascularization, and by day 7 these vascularized tumors reach a mean diameter of 8.0+2.5 mm.